Page last updated: 2024-08-21
hydrazine and sulindac
hydrazine has been researched along with sulindac in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Abulmeaty, M; Afsar, T; Algarni, A; Almajwal, A; Alruwaili, NW; Bhat, MA; Bibi, N; Inam, A; Razak, S; Shabbir, M; Trembley, JH | 1 |
Other Studies
4 other study(ies) available for hydrazine and sulindac
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Sulindac acetohydrazide derivative attenuates against cisplatin induced organ damage by modulation of antioxidant and inflammatory signaling pathways.
Topics: Antioxidants; Cisplatin; Cyclooxygenase 2; Humans; Hydrazines; Inflammation; Interleukin-1; Molecular Docking Simulation; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Signal Transduction; Sulindac; Tumor Necrosis Factor-alpha | 2022 |